Rajan Sharma
Stock Analyst at Goldman Sachs
(0.07)
# 4,482
Out of 5,182 analysts
5
Total ratings
25%
Success rate
-41.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $20.80 | -65.14% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $186.68 | -48.04% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $54.47 | -13.71% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $28.79 | +174.40% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $20.80
Upside: -65.14%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $186.68
Upside: -48.04%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $54.47
Upside: -13.71%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $28.79
Upside: +174.40%